NCT03039491View on ClinicalTrials.gov

Immune Response to Pneumococcal Vaccination in Aging HIV Positive Adults

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

September 1, 2015

Primary Completion Date

March 30, 2020

Study Completion Date

March 30, 2020

Conditions
HIV LipodystrophyAging
Interventions
BIOLOGICAL

Pneumococcal polysaccharide vaccine 23 valent

This is the pneumococcal vaccine consisting of the capsular polysaccharides of 23 serotypes of Streptococcus pneumoniae

BIOLOGICAL

13 valent conjugated pneumococcal vaccine

This is the pneumococcal vaccine consisting of the capsular polysaccharides of 13 serotypes of Streptococcus pneumoniae conjugated to non-toxic diphtheria carrier protein 197

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT03039491 - Immune Response to Pneumococcal Vaccination in Aging HIV Positive Adults | Biotech Hunter | Biotech Hunter